| (S)-amphetamine | decreases expression | ISO | RGD:733763 | 6480464 | Dextroamphetamine results in decreased expression of CYP2F2 mRNA | CTD | PMID:12205029 |
| (S)-amphetamine | multiple interactions | ISO | RGD:733763 | 6480464 | SOD1 inhibits the reaction [Dextroamphetamine results in decreased expression of CYP2F2 mRNA] | CTD | PMID:12205029 |
| 1,1-dichloroethene | increases metabolic processing | ISO | RGD:733763 | 6480464 | CYP2F2 protein results in increased metabolism of vinylidene chloride | CTD | PMID:15319346 |
| 1,1-dichloroethene | increases metabolic processing | EXP | | 6480464 | CYP2F4 protein results in increased metabolism of vinylidene chloride | CTD | PMID:15319346 |
| 1-naphthyl isothiocyanate | decreases expression | ISO | RGD:733763 | 6480464 | 1-Naphthylisothiocyanate results in decreased expression of CYP2F2 mRNA | CTD | PMID:15913567 |
| 1-nitronaphthalene | increases abundance | EXP | | 6480464 | CYP2F4 protein results in increased abundance of 1-nitronaphthalene metabolite | CTD | PMID:15509722 |
| 1-nitronaphthalene | increases abundance | ISO | RGD:733763 | 6480464 | CYP2F2 protein results in increased abundance of 1-nitronaphthalene metabolite | CTD | PMID:15509722 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:733763 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of CYP2F2 mRNA | CTD | PMID:17942748 |
| 17beta-estradiol | multiple interactions | ISO | RGD:733763 | 6480464 | Estradiol affects the reaction [CYP2F2 protein affects the abundance of naphthalene metabolite] | CTD | PMID:16085760 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1351527 | 6480464 | [Parathion co-treated with Estradiol] results in increased expression of CYP2F1 mRNA | CTD | PMID:17982697 |
| 17beta-estradiol | decreases expression | ISO | RGD:1351527 | 6480464 | Estradiol results in decreased expression of CYP2F1 mRNA | CTD | PMID:17982697 |
| 1H-pyrazole | decreases expression | ISO | RGD:733763 | 6480464 | pyrazole results in decreased expression of CYP2F2 mRNA | CTD | PMID:17945193 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:733763 | 6480464 | Tetrachlorodibenzodioxin affects the expression of CYP2F2 mRNA | CTD | PMID:16962184 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CYP2F2 mRNA | CTD | PMID:20959002 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP2F4 mRNA | CTD | PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of CYP2F4 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | AHR protein alternative form inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP2F4 mRNA] | CTD | PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:733763 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CYP2F2 mRNA | CTD | PMID:19770486 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:733763 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of CYP2F2 mRNA | CTD | PMID:17942748 |
| 3,3',4,4',5-pentachlorobiphenyl | decreases expression | EXP | | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of CYP2F2 mRNA | CTD | PMID:20959002 |
| 3-methyleneindolenine | multiple interactions | ISO | RGD:1351527 | 6480464 | [CYP2F1 protein results in increased metabolism of Skatole] which results in increased chemical synthesis of 3-methyleneindolenine | CTD | PMID:20187624 |
| 4-(ethoxymethylene)-2-phenyloxazol-5-one | decreases expression | ISO | RGD:733763 | 6480464 | Oxazolone results in decreased expression of CYP2F2 mRNA | CTD | PMID:11379042 |
| 5-fluorouracil | affects expression | ISO | RGD:1351527 | 6480464 | Fluorouracil affects the expression of CYP2F1 mRNA | CTD | PMID:16584549 |
| 6-propyl-2-thiouracil | affects expression | EXP | | 6480464 | Propylthiouracil affects the expression of CYP2F4 mRNA | CTD | PMID:19483382 |
| 8-bromo-3',5'-cyclic AMP | decreases expression | ISO | RGD:1351527 | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CYP2F1 mRNA | CTD | PMID:22079614 |
| actinomycin D | multiple interactions | ISO | RGD:1351527 | 6480464 | Dactinomycin inhibits the reaction [Skatole results in increased expression of CYP2F1 mRNA] | CTD | PMID:20187624 |
| aflatoxin B1 | decreases expression | ISO | RGD:733763 | 6480464 | Aflatoxin B1 results in decreased expression of CYP2F2 mRNA | CTD | PMID:19770486 |
| amiodarone | affects expression | EXP | | 6480464 | Amiodarone affects the expression of CYP2F4 mRNA | CTD | PMID:19483382 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of CYP2F4 mRNA | CTD | PMID:16483693 |
| benzbromarone | affects expression | EXP | | 6480464 | Benzbromarone affects the expression of CYP2F4 mRNA | CTD | PMID:19483382 |
| benzene | increases hydroxylation | ISO | RGD:733763 | 6480464 | CYP2F2 protein results in increased hydroxylation of Benzene | CTD | PMID:14718178 PMID:11718959 |
| benzene | increases hydroxylation | ISO | RGD:733763 | 6480464 | CYP2F2 protein results in increased hydroxylation of Benzene | CTD | PMID:11718959 PMID:14718178 |
| benzene | increases hydroxylation | ISO | RGD:1351527 | 6480464 | CYP2F1 protein results in increased hydroxylation of Benzene | CTD | PMID:15122651 |
| benzo[a]pyrene | decreases expression | ISO | RGD:733763 | 6480464 | Benzo(a)pyrene results in decreased expression of CYP2F2 mRNA | CTD | PMID:22228805 |
| cadmium dichloride | decreases expression | ISO | RGD:733763 | 6480464 | Cadmium Chloride results in decreased expression of CYP2F2 mRNA | CTD | PMID:11171528 |
| cadmium dichloride | decreases expression | ISO | RGD:733763 | 6480464 | Cadmium Chloride results in decreased expression of CYP2F2 mRNA | CTD | PMID:11171528 PMID:11958953 |
| cadmium dichloride | decreases expression | ISO | RGD:733763 | 6480464 | Cadmium Chloride results in decreased expression of CYP2F2 mRNA | CTD | PMID:11958953 PMID:11171528 |
| clofibrate | multiple interactions | ISO | RGD:733763 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of CYP2F2 mRNA; more ... | CTD | PMID:17585979 |
| clofibrate | affects expression | EXP | | 6480464 | Clofibrate affects the expression of CYP2F4 mRNA | CTD | PMID:19483382 |
| cycloheximide | multiple interactions | ISO | RGD:1351527 | 6480464 | Cycloheximide inhibits the reaction [Skatole results in increased expression of CYP2F1 mRNA] | CTD | PMID:20187624 |
| dibenzofuran | increases expression | EXP | | 6480464 | dibenzofuran analog results in increased expression of CYP2F4 mRNA | CTD | PMID:20566336 |
| diethylstilbestrol | decreases expression | ISO | RGD:733763 | 6480464 | Diethylstilbestrol results in decreased expression of CYP2F2 mRNA | CTD | PMID:15171707 |
| fenofibrate | multiple interactions | EXP | | 6480464 | [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of CYP2F2 mRNA | CTD | PMID:18253720 |
| flurbiprofen | increases expression | ISO | RGD:733763 | 6480464 | Flurbiprofen results in increased expression of CYP2F2 mRNA | CTD | PMID:16949054 |
| gefitinib | decreases expression | ISO | RGD:1351527 | 6480464 | gefitinib results in decreased expression of CYP2F1 mRNA | CTD | PMID:16685379 |
| indomethacin | decreases expression | EXP | | 6480464 | Indomethacin results in decreased expression of CYP2F4 mRNA | CTD | PMID:16771604 |
| kojic acid | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with kojic acid] results in increased expression of CYP2F2 mRNA; more ... | CTD | PMID:18544905 |
| L-ethionine | affects expression | EXP | | 6480464 | Ethionine affects the expression of CYP2F4 mRNA | CTD | PMID:19483382 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP2F2 mRNA; more ... | CTD | PMID:18544905 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of CYP2F2 mRNA | CTD | PMID:18253720 |
| naphthalene | increases abundance | ISO | RGD:733763 | 6480464 | CYP2F2 protein results in increased abundance of naphthalene metabolite | CTD | PMID:15509722 |
| naphthalene | decreases expression | ISO | RGD:733763 | 6480464 | naphthalene results in decreased expression of CYP2F2 protein | CTD | PMID:19438287 |
| naphthalene | multiple interactions | ISO | RGD:1351527 | 6480464 | [FGF7 protein modified form results in decreased expression of CYP2F2 mRNA] which results in decreased susceptibility to naphthalene | CTD | PMID:18385170 |
| naphthalene | decreases expression | ISO | RGD:733763 | 6480464 | naphthalene results in decreased expression of CYP2F2 mRNA | CTD | PMID:18757308 more ... |
| naphthalene | multiple interactions | ISO | RGD:733763 | 6480464 | CYP2F2 protein results in increased metabolism of and results in increased susceptibility to naphthalene | CTD | PMID:21730012 PMID:22003090 |
| naphthalene | increases metabolic processing | ISO | RGD:733763 | 6480464 | CYP2F2 protein results in increased metabolism of naphthalene | CTD | PMID:21730012 PMID:9293621 |
| naphthalene | increases abundance | EXP | | 6480464 | CYP2F2 protein results in increased abundance of naphthalene metabolite | CTD | PMID:15509722 |
| naphthalene | multiple interactions | ISO | RGD:733763 | 6480464 | Estradiol affects the reaction [CYP2F2 protein affects the abundance of naphthalene metabolite] | CTD | PMID:16085760 |
| naphthalene | decreases expression | ISO | RGD:733763 | 6480464 | naphthalene results in decreased expression of CYP2F2 mRNA | CTD | PMID:20554700 |
| naphthalene | increases metabolic processing | ISO | RGD:733763 | 6480464 | CYP2F2 protein results in increased metabolism of naphthalene | CTD | PMID:9293621 |
| naphthalene | multiple interactions | ISO | RGD:1351527 | 6480464 | ASCL1 protein inhibits the reaction [naphthalene results in decreased expression of CYP2F2 mRNA] | CTD | PMID:20554700 |
| nickel atom | decreases expression | ISO | RGD:733763 | 6480464 | Nickel results in decreased expression of CYP2F2 mRNA | CTD | PMID:12540486 |
| nickel sulfate | affects expression | ISO | RGD:733763 | 6480464 | nickel sulfate affects the expression of CYP2F2 mRNA | CTD | PMID:12718980 |
| nickel sulfate | decreases expression | ISO | RGD:733763 | 6480464 | nickel sulfate results in decreased expression of CYP2F2 mRNA | CTD | PMID:16100012 |
| nonanoic acid | decreases expression | ISO | RGD:733763 | 6480464 | pelargonic acid results in decreased expression of CYP2F2 mRNA | CTD | PMID:11379042 |
| ochratoxin A | decreases expression | EXP | | 6480464 | ochratoxin A results in decreased expression of CYP2F4 mRNA | CTD | PMID:17483316 |
| oleanolic acid | decreases expression | ISO | RGD:733763 | 6480464 | Oleanolic Acid results in decreased expression of CYP2F2 mRNA | CTD | PMID:18706400 |
| omeprazole | affects expression | EXP | | 6480464 | Omeprazole affects the expression of CYP2F4 mRNA | CTD | PMID:19483382 |
| ozone | decreases expression | ISO | RGD:733763 | 6480464 | Ozone results in decreased expression of CYP2F2 mRNA | CTD | PMID:9700096 PMID:12763052 |
| ozone | decreases expression | ISO | RGD:733763 | 6480464 | Ozone results in decreased expression of CYP2F2 mRNA | CTD | PMID:12763052 PMID:9700096 |
| paracetamol | multiple interactions | ISO | RGD:733763 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of CYP2F2 mRNA; more ... | CTD | PMID:17585979 |
| paracetamol | affects expression | ISO | RGD:733763 | 6480464 | Acetaminophen affects the expression of CYP2F2 mRNA | CTD | PMID:17562736 |
| paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of CYP2F4 mRNA | CTD | PMID:16328009 |
| parathion | increases expression | ISO | RGD:1351527 | 6480464 | Parathion results in increased expression of CYP2F1 mRNA | CTD | PMID:17982697 |
| parathion | multiple interactions | ISO | RGD:1351527 | 6480464 | [Parathion co-treated with Estradiol] results in increased expression of CYP2F1 mRNA | CTD | PMID:17982697 |
| perfluorooctane-1-sulfonic acid | affects expression | ISO | RGD:733763 | 6480464 | perfluorooctane sulfonic acid affects the expression of CYP2F2 mRNA | CTD | PMID:19429403 |
| perfluorooctane-1-sulfonic acid | increases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in increased expression of CYP2F4 mRNA | CTD | PMID:22237054 |
| perfluorooctane-1-sulfonic acid | decreases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in decreased expression of CYP2F4 mRNA | CTD | PMID:19162173 |
| perfluorooctanoic acid | affects expression | ISO | RGD:733763 | 6480464 | perfluorooctanoic acid affects the expression of CYP2F2 mRNA | CTD | PMID:19429403 |
| perfluorooctanoic acid | decreases expression | EXP | | 6480464 | perfluorooctanoic acid results in decreased expression of CYP2F4 mRNA | CTD | PMID:19162173 |
| phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of CYP2F1 mRNA | CTD | PMID:15596064 |
| phenol | increases metabolic processing | ISO | RGD:733763 | 6480464 | CYP2F2 protein results in increased metabolism of Phenol | CTD | PMID:11701230 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:733763 | 6480464 | [sodium arsenite co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CYP2F2 mRNA | CTD | PMID:16368122 |
| pirinixic acid | affects expression | EXP | | 6480464 | pirinixic acid affects the expression of CYP2F4 mRNA | CTD | PMID:19483382 |
| pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of CYP2F4 mRNA | CTD | PMID:19162173 PMID:22484513 |
| pirinixic acid | decreases expression | ISO | RGD:733763 | 6480464 | pirinixic acid results in decreased expression of CYP2F2 mRNA | CTD | PMID:15302862 more ... |
| pirinixic acid | decreases expression | ISO | RGD:733763 | 6480464 | pirinixic acid results in decreased expression of CYP2F2 mRNA | CTD | PMID:15302862 more ... |
| pirinixic acid | decreases expression | ISO | RGD:733763 | 6480464 | pirinixic acid results in decreased expression of CYP2F2 mRNA | CTD | PMID:15375163 more ... |
| pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of CYP2F4 mRNA | CTD | PMID:19162173 |
| pirinixic acid | multiple interactions | ISO | RGD:733763 | 6480464 | [pirinixic acid co-treated with PPARA] results in decreased expression of CYP2F2 mRNA | CTD | PMID:20813756 |
| pirinixic acid | decreases expression | ISO | RGD:733763 | 6480464 | pirinixic acid results in decreased expression of CYP2F2 mRNA | CTD | PMID:15375163 more ... |
| pregnenolone 16alpha-carbonitrile | decreases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in decreased expression of CYP2F4 mRNA | CTD | PMID:19162173 |
| pregnenolone 16alpha-carbonitrile | increases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in increased expression of CYP2F1 mRNA | CTD | PMID:15596064 |
| sevoflurane | affects expression | EXP | | 6480464 | sevoflurane affects the expression of CYP2F4 mRNA | CTD | PMID:15967596 |
| skatole | multiple interactions | ISO | RGD:1351527 | 6480464 | CYP2F1 protein results in increased metabolism of and results in increased activity of Skatole | CTD | PMID:20795680 |
| skatole | increases metabolic processing | ISO | RGD:1351527 | 6480464 | CYP2F1 protein results in increased metabolism of Skatole | CTD | PMID:20187624 |
| skatole | increases expression | ISO | RGD:1351527 | 6480464 | Skatole metabolite results in increased expression of CYP2F1 mRNA | CTD | PMID:20187624 |
| skatole | multiple interactions | ISO | RGD:1351527 | 6480464 | 1-aminobenzotriazole inhibits the reaction [Skatole results in increased expression of CYP2F1 mRNA]; more ... | CTD | PMID:20187624 |
| styrene | increases metabolic processing | ISO | RGD:733763 | 6480464 | CYP2F2 protein results in increased metabolism of Styrene | CTD | PMID:22386858 |
| styrene | increases response to substance | ISO | RGD:733763 | 6480464 | CYP2F2 protein results in increased susceptibility to Styrene | CTD | PMID:22386858 |
| styrene oxide | increases chemical synthesis | ISO | RGD:733763 | 6480464 | CYP2F2 protein results in increased chemical synthesis of styrene oxide | CTD | PMID:22386858 |
| thioacetamide | affects expression | EXP | | 6480464 | Thioacetamide affects the expression of CYP2F4 mRNA | CTD | PMID:19483382 |
| toluene 2,4-diisocyanate | decreases expression | ISO | RGD:733763 | 6480464 | Toluene 2,4-Diisocyanate results in decreased expression of CYP2F2 mRNA | CTD | PMID:11379042 |
| trichloroethene | decreases expression | ISO | RGD:733763 | 6480464 | Trichloroethylene results in decreased expression of CYP2F2 mRNA | CTD | PMID:19448997 |
| zinc atom | increases expression | ISO | RGD:1351527 | 6480464 | Zinc deficiency results in increased expression of CYP2F1 mRNA | CTD | PMID:18356318 |
| zinc(0) | increases expression | ISO | RGD:1351527 | 6480464 | Zinc deficiency results in increased expression of CYP2F1 mRNA | CTD | PMID:18356318 |